Bo Hou
- Biomedical Engineering top 2%
- Immunology top 5%
- Molecular Biology
- Oncology top 5%
- Biomaterials top 2%
- Co-authors
- Haijun YuYaping LiBing FengZhiai XuMadiha SaeedDangge WangLei ZhouFangyuan Zhou
- Topics
- Nanoplatforms for cancer theranostics (9 papers)Immunotherapy and Immune Responses (7 papers)Immune cells in cancer (6 papers)
In The Last Decade
Bo Hou
17 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Biomedical Engineering 1.2k
- Immunology 782
- Molecular Biology 519
- Oncology 466
- Biomaterials 423
Countries citing papers authored by Bo Hou
This map shows the geographic impact of Bo Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Hou more than expected).
Fields of papers citing papers by Bo Hou
This network shows the impact of papers produced by Bo Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Hou. The network helps show where Bo Hou may publish in the future.
Co-authorship network of co-authors of Bo Hou
This figure shows the co-authorship network connecting the top 25 collaborators of Bo Hou. A scholar is included among the top collaborators of Bo Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Hou. Bo Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 53 | |
| 4 | Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapybreakdown → | 143 |
| 5 | 28 | |
| 6 | 24 | |
| 7 | 17 | |
| 8 | 47 | |
| 9 | 12 | |
| 10 | 125 | |
| 11 | 123 | |
| 12 | 93 | |
| 13 | 39 | |
| 14 | 230 | |
| 15 | 180 | |
| 16 | 187 | |
| 17 | Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironmentbreakdown → | 404 |
About Bo Hou
Bo Hou is a scholar working on Immunology, Oncology and Biomedical Engineering, having authored 17 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), Immunotherapy and Immune Responses (7 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Immunology (782 citations), Biomaterials (423 citations) and Biomedical Engineering (1.2k citations). Bo Hou has collaborated with scholars based in China and Macao. Frequent co-authors include Haijun Yu, Yaping Li, Bing Feng, Zhiai Xu, Madiha Saeed, Dangge Wang, Lei Zhou, Fangyuan Zhou, Tingting Wang and Yuting Ma. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.